Massachusetts General Hospital SC-9 — Boston, Massachusetts

Massachusetts General Hospital SC-9 is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

Massachusetts General Hospital SC-9 has participated in 2 clinical trials.

Therapeutic areas: Advanced Solid Tumor, Early Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts General Hospital SC-9?

Massachusetts General Hospital SC-9 has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts General Hospital SC-9 conducted?

Massachusetts General Hospital SC-9 has 2 clinical trials on record. Their work covers Advanced Solid Tumor, Early Breast Cancer.

Is Massachusetts General Hospital SC-9 accredited by Crixeo Health?

Massachusetts General Hospital SC-9 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts General Hospital SC-9?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.